(Q38208961)

31 August 2017

title

Aldosterone excess and resistant hypertension: investigation and treatment (English)

1 reference

31 August 2017

Michael Stowasser

1

1 reference

31 August 2017

publication date

1 July 2014

1 reference

Current Hypertension Reports

31 August 2017

published in

1 reference

31 August 2017

volume

16

1 reference

31 August 2017

issue

7

1 reference

31 August 2017

page(s)

439

1 reference

Hyperaldosteronism among black and white subjects with resistant hypertension

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Cardiovascular outcomes in patients with primary aldosteronism after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Renal damage in primary aldosteronism: results of the PAPY Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

New perspectives on the role of aldosterone excess in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Long-term cardio- and cerebrovascular events in patients with primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Prevalence and characteristics of the metabolic syndrome in primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn's Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Adiponectin and insulin sensitivity in primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Genes implicated in insulin resistance are down-regulated in primary aldosteronism patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Aldosterone excess impairs first phase insulin secretion in primary aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Alterations in vascular function in primary aldosteronism: a cardiovascular magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Contrast-enhanced MRI index of diffuse myocardial fibrosis is increased in primary aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Sleep apnea, aldosterone, and resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Psychological assessment of primary aldosteronism: a controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Episodic rage associated with primary aldosteronism resolved with adrenalectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Reference values for aldosterone-renin ratios in normotensive individuals and effect of changes in dietary sodium consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Effects of two selective serotonin reuptake inhibitor antidepressants, sertraline and escitalopram, on aldosterone/renin ratio in normotensive depressed male patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

NT-proBNP, a useful tool in hypertensive patients undergoing a diagnostic evaluation for primary aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Captopril suppression: limitations for confirmation of primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Diagnosis and management of primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Comparison of the saline infusion test and the fludrocortisone suppression test for the diagnosis of primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

High rate of detection of primary aldosteronism, including surgically treatable forms, after ???non-selective??? screening of hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Role for adrenal venous sampling in primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Adrenal histologic findings show no difference in clinical presentation and outcome in primary hyperaldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Adrenal venous sampling: evaluation of the German Conn's registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Efficacy of adrenal venous sampling is increased by point of care cortisol analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Adrenal vein sampling: how to make it quick, easy, and successful

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Evaluation of right adrenal vein cannulation by computed tomography angiography in 140 consecutive patients undergoing adrenal venous sampling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Isoform-specific monoclonal antibodies against 3β-hydroxysteroid dehydrogenase/isomerase family provide markers for subclassification of human primary aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

The current epidemic of primary aldosteronism: causes and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Primary aldosteronism: evidence against a second epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Adrenalectomy improves arterial stiffness in primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Observational study mortality in treated primary aldosteronism: the German Conn's registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Quantitation of aldosterone in human plasma by ultra high performance liquid chromatography tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Determination of serum aldosterone by liquid chromatography and tandem mass spectrometry: a liquid-liquid extraction method for the ABSCIEX API-5000 mass spectrometry system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Development and evaluation of an immuno-MALDI (iMALDI) assay for angiotensin I and the diagnosis of secondary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Laparoscopic single site adrenalectomy using a conventional laparoscope and instrumentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Discovery of BAY 94-8862: a nonsteroidal antagonist of the mineralocorticoid receptor for the treatment of cardiorenal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

A new mode of mineralocorticoid receptor antagonism by a potent and selective nonsteroidal molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Unilateral adrenalectomy improves urinary protein excretion but does not abolish its relationship to sodium excretion in patients with aldosterone-producing adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Increased dietary sodium is related to severity of obstructive sleep apnea in patients with resistant hypertension and hyperaldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

KCNJ5 Mutations in European Families With Nonglucocorticoid Remediable Familial Hyperaldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Cardiovascular Complications Associated With Primary Aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

A Clinical Prediction Score to Diagnose Unilateral Primary Aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Sequential comparison of aldosterone synthase inhibition and mineralocorticoid blockade in patients with primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

A prospective evaluation of postural stimulation testing, computed tomography and adrenal vein sampling in the differential diagnosis of primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Prognostic value of semiquantification NP-59 SPECT/CT in primary aldosteronism patients after adrenalectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0439-7

Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study

21 January 2018

1 reference

12 December 2020

Left ventricular changes in primary aldosteronism

1 reference

12 December 2020

Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma

1 reference

12 December 2020

Unilateral adrenal hyperplasia: A novel cause of surgically correctable primary hyperaldosteronism

1 reference

12 December 2020

Effect of contraceptives on aldosterone/renin ratio may vary according to the components of contraceptive, renin assay method, and possibly route of administration

1 reference

12 December 2020

Predictive factors of left ventricular mass changes after treatment of primary aldosteronism

1 reference

12 December 2020

Primary aldosteronism: are we missing the wood for the trees?

1 reference

12 December 2020

Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal venous sampling in primary aldosteronism

1 reference

12 December 2020

Single-incision laparoscopic adrenalectomy for primary aldosteronism: report of a case

1 reference

12 December 2020

Primary aldosteronism

1 reference

12 December 2020

Intraprocedural cortisol measurement increases adrenal vein sampling success rate in primary aldosteronism

1 reference

12 December 2020

A marked proportional rise in IVC aldosterone following cosyntropin administration during AVS is a signal to the presence of adrenal hyperplasia in primary aldosteronism

1 reference

12 December 2020

A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension

1 reference

12 December 2020

Modification of the protocol for selective adrenal venous sampling results in both a significant increase in the accuracy and necessity of the procedure in the management of patients with primary hyperaldosteronism

1 reference

12 December 2020

Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy

1 reference

12 December 2020

Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism

1 reference

12 December 2020

Success of surgery for primary aldosteronism judged by residual autonomous aldosterone production

1 reference

12 December 2020

A liquid chromatography tandem mass spectrometry assay for plasma renin activity using online solid-phase extraction

1 reference

12 December 2020

Factors influencing outcome of surgery for primary aldosteronism

1 reference

12 December 2020

Cardiovascular changes in patients with primary aldosteronism after surgical or medical treatment

1 reference

12 December 2020

Laboratory investigation of primary aldosteronism.

1 reference

12 December 2020

Ultimately we are in furious agreement

1 reference

12 December 2020

Primary aldosteronism

1 reference

12 December 2020

Plasma metanephrine for assessing the selectivity of adrenal venous sampling

1 reference

12 December 2020

Primary aldosteronism associated with subclinical Cushing syndrome.

1 reference

12 December 2020

Diagnosing unilateral primary aldosteronism - comparison of a clinical prediction score, computed tomography and adrenal venous sampling.

1 reference

12 December 2020

Immunohistochemistry improves histopathologic diagnosis in primary aldosteronism

1 reference

12 December 2020

Are catecholamine-derived indexes in adrenal venous sampling useful for judging selectivity and laterality in patients with primary aldosteronism?

1 reference

12 December 2020

Are women more at risk of false-positive primary aldosteronism screening and unnecessary suppression testing than men?

1 reference

12 December 2020

Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism

1 reference

12 December 2020

Right adrenal venography findings correlated with C-arm CT for selection during C-arm CT-assisted adrenal vein sampling in primary aldosteronism.

1 reference

12 December 2020

10.1007/S11906-014-0439-7

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

1035941408

0 references

1 reference